Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The global market for Novel Drug Delivery Systems was estimated to be worth US$ 24300 million in 2023 and is forecast to a readjusted size of US$ 27380 million by 2030 with a CAGR of 1.7% during the forecast period 2024-2030.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems.
The Novel Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein鈥揹rug Conjugates
Others
Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Novel Drug Delivery Systems in global and regional level.
Chapter 3: Detailed analysis of Novel Drug Delivery Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Novel Drug Delivery Systems revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Novel Drug Delivery Systems Product Introduction
1.2 Market by Type
1.2.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein鈥揹rug Conjugates
1.2.6 Others
1.3 Market by Application
1.3.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Novel Drug Delivery Systems Market Size Estimates and Forecasts
2.2 Novel Drug Delivery Systems Market Size by Region: 2023 Versus 2030
2.2.1 Global Novel Drug Delivery Systems Revenue by Region: 2019-2024
2.2.2 Global Novel Drug Delivery Systems Revenue Forecast by Region (2025-2030)
2.2.3 Global Novel Drug Delivery Systems Revenue Market Share by Region (2019-2030)
3 Global Novel Drug Delivery Systems by Company
3.1 Global Novel Drug Delivery Systems Revenue by Company (2019-2024)
3.2 Global Novel Drug Delivery Systems Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Novel Drug Delivery Systems Companies around the World: Ranking by Revenue
3.3.2 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Novel Drug Delivery Systems Companies Headquarters & Product Type
3.4.1 Novel Drug Delivery Systems Companies Headquarters
3.4.2 Global Novel Drug Delivery Systems Companies Product & Service
3.4.3 Date of International Companies Enter into Novel Drug Delivery Systems Market
3.5 Global Novel Drug Delivery Systems Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Amgen
4.1.1 Amgen Company Information
4.1.2 Amgen Description, Business Overview
4.1.3 Amgen Novel Drug Delivery Systems Products Offered
4.1.4 Amgen Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.1.5 Amgen Novel Drug Delivery Systems Revenue by Product in 2023
4.1.6 Amgen Novel Drug Delivery Systems Revenue by Application in 2023
4.1.7 Amgen Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.1.8 Amgen Recent Developments
4.2 Teva
4.2.1 Teva Company Information
4.2.2 Teva Description, Business Overview
4.2.3 Teva Novel Drug Delivery Systems Products Offered
4.2.4 Teva Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.2.5 Teva Novel Drug Delivery Systems Revenue by Product in 2023
4.2.6 Teva Novel Drug Delivery Systems Revenue by Application in 2023
4.2.7 Teva Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.2.8 Teva Recent Developments
4.3 Roche
4.3.1 Roche Company Information
4.3.2 Roche Description, Business Overview
4.3.3 Roche Novel Drug Delivery Systems Products Offered
4.3.4 Roche Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.3.5 Roche Novel Drug Delivery Systems Revenue by Product in 2023
4.3.6 Roche Novel Drug Delivery Systems Revenue by Application in 2023
4.3.7 Roche Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.3.8 Roche Recent Developments
4.4 UCB (Union Chimique Belge)
4.4.1 UCB (Union Chimique Belge) Company Information
4.4.2 UCB (Union Chimique Belge) Description, Business Overview
4.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Products Offered
4.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.4.5 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue by Product in 2023
4.4.6 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue by Application in 2023
4.4.7 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.4.8 UCB (Union Chimique Belge) Recent Developments
4.5 Celgene
4.5.1 Celgene Company Information
4.5.2 Celgene Description, Business Overview
4.5.3 Celgene Novel Drug Delivery Systems Products Offered
4.5.4 Celgene Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.5.5 Celgene Novel Drug Delivery Systems Revenue by Product in 2023
4.5.6 Celgene Novel Drug Delivery Systems Revenue by Application in 2023
4.5.7 Celgene Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.5.8 Celgene Recent Developments
4.6 Merck
4.6.1 Merck Company Information
4.6.2 Merck Description, Business Overview
4.6.3 Merck Novel Drug Delivery Systems Products Offered
4.6.4 Merck Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.6.5 Merck Novel Drug Delivery Systems Revenue by Product in 2023
4.6.6 Merck Novel Drug Delivery Systems Revenue by Application in 2023
4.6.7 Merck Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.6.8 Merck Recent Development
4.7 Gilead Sciences
4.7.1 Gilead Sciences Company Information
4.7.2 Gilead Sciences Description, Business Overview
4.7.3 Gilead Sciences Novel Drug Delivery Systems Products Offered
4.7.4 Gilead Sciences Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.7.5 Gilead Sciences Novel Drug Delivery Systems Revenue by Product in 2023
4.7.6 Gilead Sciences Novel Drug Delivery Systems Revenue by Application in 2023
4.7.7 Gilead Sciences Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.7.8 Gilead Sciences Recent Development
4.8 Sanofi
4.8.1 Sanofi Company Information
4.8.2 Sanofi Description, Business Overview
4.8.3 Sanofi Novel Drug Delivery Systems Products Offered
4.8.4 Sanofi Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.8.5 Sanofi Novel Drug Delivery Systems Revenue by Product in 2023
4.8.6 Sanofi Novel Drug Delivery Systems Revenue by Application in 2023
4.8.7 Sanofi Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.8.8 Sanofi Recent Development
4.9 Pfizer
4.9.1 Pfizer Company Information
4.9.2 Pfizer Description, Business Overview
4.9.3 Pfizer Novel Drug Delivery Systems Products Offered
4.9.4 Pfizer Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.9.5 Pfizer Novel Drug Delivery Systems Revenue by Product in 2023
4.9.6 Pfizer Novel Drug Delivery Systems Revenue by Application in 2023
4.9.7 Pfizer Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.9.8 Pfizer Recent Development
4.10 Takeda
4.10.1 Takeda Company Information
4.10.2 Takeda Description, Business Overview
4.10.3 Takeda Novel Drug Delivery Systems Products Offered
4.10.4 Takeda Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.10.5 Takeda Novel Drug Delivery Systems Revenue by Product in 2023
4.10.6 Takeda Novel Drug Delivery Systems Revenue by Application in 2023
4.10.7 Takeda Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.10.8 Takeda Recent Development
4.11 Bausch&Lomb
4.11.1 Bausch&Lomb Company Information
4.11.2 Bausch&Lomb Description, Business Overview
4.11.3 Bausch&Lomb Novel Drug Delivery Systems Products Offered
4.11.4 Bausch&Lomb Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.11.5 Bausch&Lomb Novel Drug Delivery Systems Revenue by Product in 2023
4.11.6 Bausch&Lomb Novel Drug Delivery Systems Revenue by Application in 2023
4.11.7 Bausch&Lomb Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.11.8 Bausch&Lomb Recent Development
4.12 Samyang Biopharmaceuticals
4.12.1 Samyang Biopharmaceuticals Company Information
4.12.2 Samyang Biopharmaceuticals Description, Business Overview
4.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Products Offered
4.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.12.5 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue by Product in 2023
4.12.6 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue by Application in 2023
4.12.7 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.12.8 Samyang Biopharmaceuticals Recent Development
4.13 Johnson & Johnson
4.13.1 Johnson & Johnson Company Information
4.13.2 Johnson & Johnson Description, Business Overview
4.13.3 Johnson & Johnson Novel Drug Delivery Systems Products Offered
4.13.4 Johnson & Johnson Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.13.5 Johnson & Johnson Novel Drug Delivery Systems Revenue by Product in 2023
4.13.6 Johnson & Johnson Novel Drug Delivery Systems Revenue by Application in 2023
4.13.7 Johnson & Johnson Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.13.8 Johnson & Johnson Recent Development
4.14 TOLMAR
4.14.1 TOLMAR Company Information
4.14.2 TOLMAR Description, Business Overview
4.14.3 TOLMAR Novel Drug Delivery Systems Products Offered
4.14.4 TOLMAR Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.14.5 TOLMAR Novel Drug Delivery Systems Revenue by Product in 2023
4.14.6 TOLMAR Novel Drug Delivery Systems Revenue by Application in 2023
4.14.7 TOLMAR Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.14.8 TOLMAR Recent Development
4.15 Astellas
4.15.1 Astellas Company Information
4.15.2 Astellas Description, Business Overview
4.15.3 Astellas Novel Drug Delivery Systems Products Offered
4.15.4 Astellas Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.15.5 Astellas Novel Drug Delivery Systems Revenue by Product in 2023
4.15.6 Astellas Novel Drug Delivery Systems Revenue by Application in 2023
4.15.7 Astellas Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.15.8 Astellas Recent Development
4.16 AMAG Pharmaceuticals
4.16.1 AMAG Pharmaceuticals Company Information
4.16.2 AMAG Pharmaceuticals Description, Business Overview
4.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Products Offered
4.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.16.5 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue by Product in 2023
4.16.6 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue by Application in 2023
4.16.7 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.16.8 AMAG Pharmaceuticals Recent Development
4.17 AbbVie
4.17.1 AbbVie Company Information
4.17.2 AbbVie Description, Business Overview
4.17.3 AbbVie Novel Drug Delivery Systems Products Offered
4.17.4 AbbVie Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.17.5 AbbVie Novel Drug Delivery Systems Revenue by Product in 2023
4.17.6 AbbVie Novel Drug Delivery Systems Revenue by Application in 2023
4.17.7 AbbVie Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.17.8 AbbVie Recent Development
4.18 Dr Reddy
4.18.1 Dr Reddy Company Information
4.18.2 Dr Reddy Description, Business Overview
4.18.3 Dr Reddy Novel Drug Delivery Systems Products Offered
4.18.4 Dr Reddy Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.18.5 Dr Reddy Novel Drug Delivery Systems Revenue by Product in 2023
4.18.6 Dr Reddy Novel Drug Delivery Systems Revenue by Application in 2023
4.18.7 Dr Reddy Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.18.8 Dr Reddy Recent Development
4.19 AstraZeneca
4.19.1 AstraZeneca Company Information
4.19.2 AstraZeneca Description, Business Overview
4.19.3 AstraZeneca Novel Drug Delivery Systems Products Offered
4.19.4 AstraZeneca Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.19.5 AstraZeneca Novel Drug Delivery Systems Revenue by Product in 2023
4.19.6 AstraZeneca Novel Drug Delivery Systems Revenue by Application in 2023
4.19.7 AstraZeneca Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.19.8 AstraZeneca Recent Development
4.20 Aspen
4.20.1 Aspen Company Information
4.20.2 Aspen Description, Business Overview
4.20.3 Aspen Novel Drug Delivery Systems Products Offered
4.20.4 Aspen Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.20.5 Aspen Novel Drug Delivery Systems Revenue by Product in 2023
4.20.6 Aspen Novel Drug Delivery Systems Revenue by Application in 2023
4.20.7 Aspen Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.20.8 Aspen Recent Development
4.21 Acrotech Biopharma
4.21.1 Acrotech Biopharma Company Information
4.21.2 Acrotech Biopharma Description, Business Overview
4.21.3 Acrotech Biopharma Novel Drug Delivery Systems Products Offered
4.21.4 Acrotech Biopharma Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.21.5 Acrotech Biopharma Novel Drug Delivery Systems Revenue by Product in 2023
4.21.6 Acrotech Biopharma Novel Drug Delivery Systems Revenue by Application in 2023
4.21.7 Acrotech Biopharma Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.21.8 Acrotech Biopharma Recent Development
4.22 TWi Pharmaceuticals
4.22.1 TWi Pharmaceuticals Company Information
4.22.2 TWi Pharmaceuticals Description, Business Overview
4.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Products Offered
4.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue and Gross Margin (2019-2024)
4.22.5 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue by Product in 2023
4.22.6 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue by Application in 2023
4.22.7 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue by Geographic Area in 2023
4.22.8 TWi Pharmaceuticals Recent Development
5 Breakdown Data by Type
5.1 Global Novel Drug Delivery Systems Revenue by Type (2019-2024)
5.2 Global Novel Drug Delivery Systems Revenue Forecast by Type (2025-2030)
5.3 Novel Drug Delivery Systems Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Novel Drug Delivery Systems Revenue by Application (2019-2024)
6.2 Global Novel Drug Delivery Systems Revenue Forecast by Application (2025-2030)
6.3 Novel Drug Delivery Systems Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Novel Drug Delivery Systems Market Size YoY Growth 2019-2030
7.2 North America Novel Drug Delivery Systems Market Facts & Figures by Country (2019-2030)
7.3 North America Novel Drug Delivery Systems Revenue by Type (2019-2024)
7.4 North America Novel Drug Delivery Systems Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Novel Drug Delivery Systems Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Novel Drug Delivery Systems Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Novel Drug Delivery Systems Revenue by Type (2019-2024)
8.4 Asia-Pacific Novel Drug Delivery Systems Revenue by Application (2019-2024)
9 Europe
9.1 Europe Novel Drug Delivery Systems Market Size YoY Growth 2019-2030
9.2 Europe Novel Drug Delivery Systems Market Facts & Figures by Country (2019-2030)
9.3 Europe Novel Drug Delivery Systems Revenue by Type (2019-2024)
9.4 Europe Novel Drug Delivery Systems Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Novel Drug Delivery Systems Market Size YoY Growth 2019-2030
10.2 Latin America Novel Drug Delivery Systems Market Facts & Figures by Country (2019-2030)
10.3 Latin America Novel Drug Delivery Systems Revenue by Type (2019-2024)
10.4 Latin America Novel Drug Delivery Systems Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Novel Drug Delivery Systems Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Novel Drug Delivery Systems Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Novel Drug Delivery Systems Revenue by Type (2019-2024)
11.4 Middle East and Africa Novel Drug Delivery Systems Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Novel Drug Delivery Systems Supply Chain Analysis
12.2 Novel Drug Delivery Systems Key Raw Materials and Upstream Suppliers
12.3 Novel Drug Delivery Systems Clients Analysis
12.4 Novel Drug Delivery Systems Sales Channel and Sales Model Analysis
12.4.1 Novel Drug Delivery Systems Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Novel Drug Delivery Systems Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Novel Drug Delivery Systems Distributors
13 Market Dynamics
13.1 Novel Drug Delivery Systems Industry Trends
13.2 Novel Drug Delivery Systems Market Drivers
13.3 Novel Drug Delivery Systems Market Challenges
13.4 Novel Drug Delivery Systems Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
听
听
*If Applicable.
